Antagen Pharmaceuticals

Antagen Pharmaceuticals is a private Boston-area biotech company, operating as Antagen Biosciences, focused on antibody discovery, glyco-engineered cell lines, and related bioscience products and services. The company says it is developing therapeutic antibodies for cancer, autoimmune, and infectious diseases while also commercializing research-use products such as antibody isotyping kits, recombinant proteins, lentivirus titration assays, and engineered cell lines. Its core technical capabilities center on antibody glyco-engineering, including afucosylated and sialylated mammalian expression systems intended to improve antibody-dependent cellular cytotoxicity and pharmacologic properties. Publicly visible evidence suggests its therapeutic pipeline remains at a preclinical stage, with patent activity around anti-CD39 immuno-oncology antibodies and no clearly disclosed clinical-stage assets. The business appears to combine elements of a therapeutics developer with research tools, contract R&D, and cell-line engineering services.